These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33755760)

  • 41. TWEAK/Fn14 Is Overexpressed in Crohn's Disease and Mediates Experimental Ileitis by Regulating Critical Innate and Adaptive Immune Pathways.
    Di Martino L; Osme A; Kossak-Gupta S; Pizarro TT; Cominelli F
    Cell Mol Gastroenterol Hepatol; 2019; 8(3):427-446. PubMed ID: 31181286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of SIRT2 Alleviates Fibroblast Activation and Renal Tubulointerstitial Fibrosis via MDM2.
    He FF; You RY; Ye C; Lei CT; Tang H; Su H; Zhang C
    Cell Physiol Biochem; 2018; 46(2):451-460. PubMed ID: 29614506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tubulointerstitial de novo expression of the α8 integrin chain in a rodent model of renal fibrosis--a potential target for anti-fibrotic therapy?
    Hartner A; Menendez-Castro C; Cordasic N; Marek I; Volkert G; Klanke B; Rascher W; Hilgers KF
    PLoS One; 2012; 7(11):e48362. PubMed ID: 23144868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.
    Han ES; Mekasha S; Ingalls RR
    J Reprod Immunol; 2010 Jan; 84(1):16-23. PubMed ID: 19963275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK)/Fibroblast Growth Factor-Inducible 14 (Fn14) Axis in Cardiovascular Diseases: Progress and Challenges.
    Méndez-Barbero N; Gutiérrez-Muñoz C; Blázquez-Serra R; Martín-Ventura JL; Blanco-Colio LM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32053869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tweak/Fn14 system is involved in rhabdomyolysis-induced acute kidney injury.
    Guerrero-Hue M; Vallejo-Mudarra M; García-Caballero C; Córdoba-David GM; Palomino-Antolín A; Herencia C; Vendrell-Casana B; Rubio-Navarro A; Egido J; Blanco-Colio LM; Moreno JA
    Biomed Pharmacother; 2023 Dec; 169():115925. PubMed ID: 38007933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
    Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
    Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
    Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
    Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
    Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus.
    Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C
    J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of ROCK2 alleviates renal fibrosis and the metabolic disorders in the proximal tubular epithelial cells.
    You R; Zhou W; Li Y; Zhang Y; Huang S; Jia Z; Zhang A
    Clin Sci (Lond); 2020 Jun; 134(12):1357-1376. PubMed ID: 32490513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
    Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
    J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interruption of neutrophil extracellular traps formation dictates host defense and tubular HOXA5 stability to augment efficacy of anti-Fn14 therapy against septic AKI.
    Ni Y; Hu BC; Wu GH; Shao ZQ; Zheng Y; Zhang R; Jin J; Hong J; Yang XH; Sun RH; Liu JQ; Mo SJ
    Theranostics; 2021; 11(19):9431-9451. PubMed ID: 34646379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis.
    Méndez-Barbero N; Gutierrez-Muñoz C; Madrigal-Matute J; Mínguez P; Egido J; Michel JB; Martín-Ventura JL; Esteban V; Blanco-Colio LM
    EBioMedicine; 2019 Aug; 46():274-289. PubMed ID: 31395500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.
    Muñoz-Félix JM; López-Novoa JM; Martínez-Salgado C
    Kidney Int; 2014 Feb; 85(2):319-32. PubMed ID: 23945497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.
    Beghdadi W; Madjene LC; Claver J; Pejler G; Beaudoin L; Lehuen A; Daugas E; Blank U
    Kidney Int; 2013 Aug; 84(2):317-26. PubMed ID: 23515052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis.
    Prakash J; de Borst MH; van Loenen-Weemaes AM; Lacombe M; Opdam F; van Goor H; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
    Pharm Res; 2008 Oct; 25(10):2427-39. PubMed ID: 18183478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
    Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
    PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.